| 10/20/2020 |
Is Amgen Stock A Buy With No Recent Updates On Its Dual Approach To Targeting Coronavirus? |
thenewsdoctors.com |
... in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2024. The report includes detailed breakouts for 14 countries and 5 regions. Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the ... |
| 10/19/2020 |
Genetic Testing Market to Reach $21.26 Bn, Globally, by 2027 at 10.1% CAGR: Allied Market Research |
PR Newswire |
PORTLAND, Ore. , Oct. 19, 2020 / PRNewswire / -- Allied Market Research published a report, titled, " Genetic Testing Market by Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing , and Others), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), Application (Cancer diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027" According to the report, the global genetic testing industry was estimated ... |
| 10/13/2020 |
Inozyme Pharma Appoints Yves Sabbagh, Ph.D., as Senior Vice President and Chief Scientific Officer |
Globe Newswire |
... in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2024. The report includes detailed breakouts for 14 countries and 5 regions.Predictive Diagnostics? Pharmacogenomic Testing ? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the ... |
| 9/13/2020 |
Study Finds Improved MDD Outcomes With Pharmacogenomic Test |
psychcongress.com |
Study Finds Improved MDD Outcomes With Pharmacogenomic Test September 13, 2020 Pharmacogenomic testing using the using GeneSight Psychotropic test was associated with improved outcomes in patients with major depressive disorder (MDD) who failed to improve with previous antidepressant treatment, according to a meta-analysis presented in a poster at Psych Congress 2020 . “Pharmacogenomic testing is a potential tool to inform clinicians’ treatment decisions for patients with major depressive disorder,” researchers ... |
| 9/8/2020 |
ClinOne Partners with CQuentia to Add COVID-19 and Comprehensive Precision Medicine Testing to Their Suite of Clinical Trial Operating Services and Virtual Trials |
Business Wire |
... a sophisticated precision medicine platform to ClinOne’s suite of resources. Among the tests conducted by CQuentia and made available through ClinOne are COVID-19 RT-PCR and Antibody tests, Respiratory Pathogen Panel (RPP) and Pharmacogenomic testing (PGx). CQuentia’s testing improves the overall well-being of patients by reducing risk and enhancing safety protocols. Esterl explains that “such actionable and customized clinical information aligns with our clients to expand virtual clinical ... |
| 9/8/2020 |
Genetic Testing Services Market Business Growth, Development Factors, Applications, and Future Prospects |
sciexaminer.com |
... 10235 New Born Screening Segment to Dominate Global Genetic Testing Services Market In terms of test type, the global genetic testing services market has been segmented into prenatal testing, newborn screening, predictive & presymptomatic testing, pharmacogenomic testing , and others. New Born Screening segment likely to grow at highest growth care during forecast period. Rise in neonatal diseases, and increasing pediatric patients suffering from diseases are propelling factor for the segment growth ... |
| 9/1/2020 |
HHS Limits FDA Oversight of LDTs Without Formal Rulemaking, Including During COVID-19 Pandemic |
jdsupra.com |
... that it reserves the right to regulate certain LDTs if FDA determines such oversight may be required to protect the public health. For example, FDA previously has taken enforcement action against LDTs intended for pharmacogenomic testing . More recently, in response to the coronavirus (COVID-19) pandemic, FDA has required clinical laboratories that develop and use diagnostic LDTs for SARS-CoV-2 (including molecular and antigen tests) to submit an EUA ... |
| 9/1/2020 |
Genetic Testing Services Market: Surge in Adoption of Genetic Testing Services to Boost the Market |
BioSpace |
... 10235 New Born Screening Segment to Dominate Global Genetic Testing Services Market In terms of test type, the global genetic testing services market has been segmented into prenatal testing, newborn screening, predictive & presymptomatic testing, pharmacogenomic testing , and others. New Born Screening segment likely to grow at highest growth care during forecast period. Rise in neonatal diseases, and increasing pediatric patients suffering from diseases are propelling factor for the segment growth ... |
| 8/28/2020 |
Global Genetic Testing Industry Outlook to 2023 with Market Shares by Key Players |
PR Newswire |
... in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions. Predictive Diagnostics? Pharmacogenomic Testing ? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the ... |
| 8/26/2020 |
World Genetic Testing Industry Assessment 2019-2023: Volumes, Prices and Revenues by Test |
Benzinga |
... in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions. Predictive Diagnostics? Pharmacogenomic Testing ? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the ... |
| 8/26/2020 |
|
malvern-online.com |
... in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions. Predictive Diagnostics? Pharmacogenomic Testing ? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the ... |
| 8/26/2020 |
World Genetic Testing Industry Assessment 2019-2023: Volumes, Prices and Revenues by Test |
Globe Newswire |
... in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2023. The report includes detailed breakouts for 14 countries and 5 regions. Predictive Diagnostics? Pharmacogenomic Testing ? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for the ... |
| 8/26/2020 |
Global Genetic Testing Market Size Forecast to 2023 - ResearchAndMarkets.com | Business & Finance | manchestertimes.com |
Business Wire |
... Acquired for $33 Million in Invitae Common Stock 5. Country Market Sizes - North America 5.1 United States of America 5.1.1 Prenatal and Newborn Testing - Volumes, Prices, Revenues 5.1.2 Predictive Testing - Volumes, Prices, Revenues 5.1.3 Pharmacogenomic Testing - Volumes, Prices, Revenues 5.1.4 Direct to Consumer Testing - Volumes, Prices, Revenues 5.1.5 All Genetic testing - Volumes, Prices, Revenues 5.2 Canada ... |
| 8/13/2020 |
Genetic testing could help patients find better treatment for depression, psychiatrist says |
wspa.com |
Aug 13, 2020 / 10:09 AM EDT / Updated: Aug 13, 2020 / 03:46 PM EDT GREENVILLE, S.C. (WSPA) – A Greenville psychiatrist said pharmacogenomic testing could help patients find better treatment for major depressive disorder, particularly if they are not noticing any improvement or are noticing negative side effects from their medication. “By just doing a simple cheek swab, the provider could get a list of the medicines that would have no gene ... |
| 8/4/2020 |
Digital Health Veteran Derek Newell Joins as President of LetsGetChecked |
Business Wire |
... of testing options cover a wide range of major health issues such as diabetes and cardiovascular disease. The company also provides testing options for cancer screening, sexual health testing, fertility testing, wellness testing and pharmacogenomic testing among others. About LetsGetChecked: LetsGetChecked is a leading health insights company that allows consumers direct access to a wide range of testing options and clinical services from home. Founded in 2015, the company empowers ... |
| 7/28/2020 |
Valparaiso lab offers saliva COVID-19 test instead of nasal swab |
nwitimes.com |
Great Lakes Labs in Valparaiso is believed to be the only laboratory in the area offering the saliva test for COVID-19. The company has provided forensic services for the criminal justice system for more than a third of a century. It also provides pharmacogenomic testing to provide information about how prescription drugs would interact with a person’s genetic makeup. That can be useful in tailoring a prescription plan in ... |
| 7/1/2020 |
Identification of populations likely to benefit from pharmacogenomic testing |
lww.com |
Abstract Objectives Pharmacogenomic testing (PGX) implementation is rapidly expanding, including pre-emptive testing funded by health systems. PGX continues to develop an evidence base that it saves money and improves clinical outcomes. Identifying the potential impact of pre-emptive testing in specific populations may aid in the development of a business case. Methods We utilized a software tool that can evaluate patient drug lists and identified groups of patients most ... |
| 6/17/2020 |
Myriad Genetics (NASDAQ:MYGN) Given Daily News Impact Rating of -3.53 |
American Banking News |
Palmetto GBA Issues Final Local Coverage Determination on Pharmacogenomic Testing for Medicare Beneficiaries (finance.yahoo.com) MYGN has been the subject of a number of research analyst reports. JPMorgan Chase & Co. reduced their price objective on Myriad Genetics from $14.00 to $12.00 and set an “underweight” rating for the company in a report on Wednesday, May 6th. Piper Sandler reduced their price objective on Myriad Genetics from $20.00 to $14.00 and set ... |
| 6/16/2020 |
Palmetto GBA Issues Final LCD on Pharmacogenomic Testing for Medicare Beneficiaries |
clpmag.com |
Palmetto GBA Issues Final LCD on Pharmacogenomic Testing for Medicare Beneficiaries Published on June 16, 2020 Myriad Genetics, Salt Lake City, acknowledges the release of a final local coverage determination (LCD) for pharmacogenomic (PGx) testing by Palmetto GBA, one of the administrative contractors for the Centers for Medicare and Medicaid Services. The new LCD does not restrict pharmacogenomic testing by provider type as long as the provider has the licensure ... |
| 6/15/2020 |
Genetic Testing Market Analysis 2020-2024 with Profiles of Key Companies Including Genomics, Inc, Abbott Diagnostics, Agilent, Beckman Coulter, Inc, Bioarray Genetics and More |
PR Newswire |
... in the breadth of tests creating a new life for the industry. The report forecasts the market size out to 2024. The report includes detailed breakouts for 14 countries and 5 regions. Predictive Diagnostics? Pharmacogenomic Testing ? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and pitfalls. Understand growth expectations and the ultimate market forecasts for ... |